AU2001290553A1 - Method for using activated protein c for the treatment of coagulation-associated disorders - Google Patents

Method for using activated protein c for the treatment of coagulation-associated disorders

Info

Publication number
AU2001290553A1
AU2001290553A1 AU2001290553A AU9055301A AU2001290553A1 AU 2001290553 A1 AU2001290553 A1 AU 2001290553A1 AU 2001290553 A AU2001290553 A AU 2001290553A AU 9055301 A AU9055301 A AU 9055301A AU 2001290553 A1 AU2001290553 A1 AU 2001290553A1
Authority
AU
Australia
Prior art keywords
coagulation
treatment
activated protein
associated disorders
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001290553A
Inventor
Sau-Chi Betty Yan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU2001290553A1 publication Critical patent/AU2001290553A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4866—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001290553A 2000-09-18 2001-09-17 Method for using activated protein c for the treatment of coagulation-associated disorders Abandoned AU2001290553A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23363600P 2000-09-18 2000-09-18
US60/233,636 2000-09-18
PCT/US2001/026028 WO2002024215A2 (en) 2000-09-18 2001-09-17 Method for using activated protein c for the treatment of coagulation-associated disorders

Publications (1)

Publication Number Publication Date
AU2001290553A1 true AU2001290553A1 (en) 2002-04-02

Family

ID=22878074

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001290553A Abandoned AU2001290553A1 (en) 2000-09-18 2001-09-17 Method for using activated protein c for the treatment of coagulation-associated disorders

Country Status (2)

Country Link
AU (1) AU2001290553A1 (en)
WO (1) WO2002024215A2 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0001237A3 (en) * 1997-10-20 2002-01-28 Lilly Co Eli Methods for treating vascular disorders
JP2002530353A (en) * 1998-11-20 2002-09-17 イーライ・リリー・アンド・カンパニー Treatment of viral hemorrhagic fever
DK1133314T3 (en) * 1998-11-23 2003-04-14 Lilly Co Eli Protein C for the treatment of sickle cell disease and thalassemia
JP2004511428A (en) * 2000-05-24 2004-04-15 イーライ・リリー・アンド・カンパニー Formulations and methods for treating hypercoagulable conditions

Also Published As

Publication number Publication date
WO2002024215A3 (en) 2003-05-22
WO2002024215A2 (en) 2002-03-28

Similar Documents

Publication Publication Date Title
WO2003033720A8 (en) Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders
AU2003286567A1 (en) Methods for the treatment of skin disorders
AU2002348135A1 (en) Methods for the treatment of addiction
AU2001249881A1 (en) Method of treating the heart
AU2003286611A1 (en) Cytomodulating peptides and methods for treating neurological disorders
AU2001288628A1 (en) Method and reagents for treatment of skin disorders by modulating the notch pathway
AU2002332430A1 (en) Methods of treating neuropilin-mediated diseases
AU2001247474A1 (en) Compounds for the treatment of psychiatric or substance abuse disorders
AU2002334870B8 (en) Combinations for the treatment of immunoinflammatory disorders
AU6910600A (en) Methods for the treatment of mental disorders
AU2002336405A1 (en) Methods for treating deodorizer distillate
AU2001285747A1 (en) Method for the treatment of tobacco
AU2001286983A1 (en) Method of treatment
AU2001257903A1 (en) Method for treatment of neurodegenerative diseases
AU2001271887A1 (en) Methods for diagnosis and treatment of psychiatric disorders
AU5042000A (en) Methods of treating proliferative disorders
AU2002245204A1 (en) Methods for treating blood coagulation disorders
AU7750100A (en) Method for the treatment of obesity
AU2002227895A1 (en) Sulphonamides for the treatment of central nervous system diseases
AU3004000A (en) Methods for the treatment of apolipoprotein e related diseases
AU2002258798A1 (en) Methods for the treatment of hepatic disorders
AU3899100A (en) Treatment of hyperactivity disorders
AU2002225327A1 (en) Apparatus for aesthetic treatment
AU2080201A (en) Treatment of addiction disorders
AU2001262177A1 (en) Method of treatment